Leading Anti-Retroviral Medicine Manufacturing Excellence from India

India has emerged as a global powerhouse in pharmaceutical manufacturing, particularly in the field of anti-retroviral (ARV) medicines. As one of the most trusted Anti-Retroviral Medicine Manufacturers in IndiaTaj Pharma Limited stands at the forefront of quality, innovation, regulatory compliance, and large-scale global supply. With over 30+ years of pharmaceutical expertise and a presence across 85+ countries, we consistently deliver reliable, affordable, and high-quality ARV formulations that meet the most stringent international standards.

Our commitment is rooted in one core objective: to ensure uninterrupted access to life-saving anti-retroviral therapies worldwide, especially in regulated and emerging markets where quality and affordability are equally critical.


Why India Is the Global Hub for Anti-Retroviral Medicines

India plays a pivotal role in the global fight against HIV/AIDS. A significant percentage of ARV medicines used in Africa, Asia, Latin America, and parts of Europe originate from Indian manufacturers. This leadership is driven by:

  • Strong regulatory frameworks
  • Advanced manufacturing infrastructure
  • Cost-efficient production models
  • Deep scientific and formulation expertise

Within this ecosystem, Taj Pharma Limited has established itself as a dependable and scalable ARV drug manufacturing partner, supporting national AIDS control programs, global NGOs, institutional tenders, and private healthcare markets.


Taj Pharma Limited – A Trusted Anti-Retroviral Medicine Manufacturer

Taj Pharma Limited is a globally recognized pharmaceutical company with a strong legacy in complex generic formulations, including anti-retroviral therapies. Our integrated approach covers formulation development, analytical research, regulatory documentation, commercial manufacturing, and global distribution.

We manufacture ARV medicines in compliance with WHO-GMP, US-FDA, EU-GMP, and UK-MHRA standards, ensuring acceptance across regulated and semi-regulated markets.

ANTIRETROVIRAL / ANTIVIRAL PRODUCTS LIST

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
Abacavir + Dolutegravir + LamivudineABDOTAJAntiretroviral (ART)Tablet600 mg / 50 mg / 300 mgII
Atazanavir + RitonavirAIFOTAJ-RAntiretroviralTablet300 mg / 100 mgII
DolutegravirDOLUTRIX / TAPIVIRAntiretroviralTablet50 mgII
Dolutegravir + Lamivudine + Tenofovir Disoproxil FumarateDOLUTENOTAJAntiretroviralTablet50 mg / 300 mg / 300 mgII
EfavirenzEFAVITAJAntiretroviralTablet600 mgII
Lopinavir + RitonavirLOPRITAJAntiretroviralTablet200 mg / 50 mgII
SofosbuvirHEPCITAJAntiviral (Hepatitis C)Tablet400 mgIII
Sofosbuvir + VelpatasvirHEPCITAJ-VAntiviral (Hepatitis C)Tablet400 mg / 100 mgIII
ValacyclovirVALACTAJAntiviralTablet1000 mgIII

State-of-the-Art Manufacturing Facilities

Unit 1 – Sarigam (Emerging Markets Manufacturing)

Our Sarigam facility is designed to support large-volume production for emerging and institutional markets while maintaining strict quality benchmarks.

Key Certifications and Capabilities:

  • WHO-GMP Certified
  • DIGEMID Peru Approved
  • ISO 9000:2015 Certified
  • EU-GMP Audit Triggered (Target: FY 2026)
  • Manufacturing of 500+ formulations
  • Dosage forms: Tablets, Capsules, Oral Liquids, Powders

This unit plays a vital role in supplying cost-optimized ARV formulations for public health programs and international procurement agencies.


Unit 2 – Viramgam (Regulated Markets Manufacturing)

Our Viramgam facility represents our excellence in regulated market compliance and high-volume production.

Regulatory Approvals:

  • US-FDA Approved
  • EU-GMP Certified
  • UK-MHRA Accredited

Production Capacity:

  • 1.2 billion tablets per year
  • 500 million capsules per year
  • Immediate expansion capability to 1.5 billion tablets and 0.5 billion capsules

This facility is ideally suited for regulated market ARV supplies, contract manufacturing, and long-term strategic partnerships.


Comprehensive Anti-Retroviral Product Manufacturing Capabilities

We manufacture a wide range of anti-retroviral medicines, covering multiple therapeutic classes used in HIV treatment protocols:

  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Protease Inhibitors (PIs)
  • Integrase Strand Transfer Inhibitors (INSTIs)
  • Fixed Dose Combinations (FDCs)

Our formulations are designed for high bioavailability, stability in tropical climates, and patient compliance, making them suitable for global distribution.


ANTIRETROVIRAL / ANTIVIRAL PRODUCTS List

Product NameBrand Name (Original)Therapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
ZidovudineRetrovirAntiretroviral (NRTI)Tablet100 mg, 300 mgIII
LamivudineEpivirAntiretroviral (NRTI)Tablet150 mg, 300 mgIII
NevirapineViramuneAntiretroviral (NNRTI)Tablet200 mgII
EfavirenzSustivaAntiretroviral (NNRTI)Tablet600 mgII
DidanosineVidexAntiretroviral (NRTI)Tablet100/150/200 mgIII
StavudineZeritAntiretroviral (NRTI)Tablet30/40 mgIII
AbacavirZiagenAntiretroviral (NRTI)Tablet300 mgIII
Atazanavir (generic)Reyataz (generic)Antiretroviral (PI)Tablet300 mgII
Ritonavir (generic)Norvir (original)Antiretroviral (PI booster)Tablet100 mgII
Lopinavir + RitonavirKaletra (generic available)Antiretroviral (PI combo)Tablet200/50 mgII
IndinavirCrixivanAntiretroviral (PI)Tablet400 mgII

Fixed-Dose Combination Generics

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
Zidovudine + LamivudineCombivir / genericAntiretroviral (NRTI combo)Tablet300/150 mgII
Abacavir + LamivudineKivexa / Epzicom genericAntiretroviral (NRTI combo)Tablet300/150 mgII
Zidovudine + Lamivudine + NevirapinegenericAntiretroviral (NRTI + NNRTI)TabletvariousII

Other Older Antiviral Drugs

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
AcyclovirZoviraxAntiviralTablet400/800 mgIII
ValacyclovirValtrexAntiviralTablet500/1000 mgIII
FamciclovirFamvirAntiviralTablet250/500 mgIII
GanciclovirCytoveneAntiviralTablet/IV250/500 mgIII
ValganciclovirValcyteAntiviralTablet450 mgIII
OseltamivirTamifluAntiviralTablet30/45/75 mgI
ZanamivirRelenzaAntiviralInhaler5 mgI

ANTIRETROVIRAL / ANTIVIRAL PRODUCTS LIST – Taj Generic Brands

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS ClassPatent Expiry in India
AbacavirABACTAJAntiretroviral (NRTI)Tablet300 mgIII2012
LamivudineLAMITAJAntiretroviral (NRTI)Tablet150/300 mgIII2005
ZidovudineZIDOTAJAntiretroviral (NRTI)Tablet100/300 mgIII2003
DidanosineDIDOTAJAntiretroviral (NRTI)Tablet100/150/200 mgIII2006
NevirapineNEVITAJAntiretroviral (NNRTI)Tablet200 mgII2007
EfavirenzEFAVITAJAntiretroviral (NNRTI)Tablet600 mgII2014
StavudineSTAVITAJAntiretroviral (NRTI)Tablet30/40 mgIII2005
Abacavir + LamivudineABLAMTAJAntiretroviral (NRTI combo)Tablet300/150 mgII2014
Zidovudine + LamivudineZIDLAMTAJAntiretroviral (NRTI combo)Tablet300/150 mgII2010
Zidovudine + Lamivudine + NevirapineZIDLAMNEVTAJAntiretroviral (NRTI+NNRTI)TabletVariousII2010
AtazanavirATAZTAJAntiretroviral (PI)Tablet300 mgII2018
RitonavirRITOTAJAntiretroviral (PI booster)Tablet100 mgII2012
Lopinavir + RitonavirLOPRITAJAntiretroviral (PI combo)Tablet200/50 mgII2012
IndinavirINDOTAJAntiretroviral (PI)Tablet400 mgII2007
AcyclovirACYTTAJAntiviralTablet400/800 mgIIIGeneric
ValacyclovirVALACTAJAntiviralTablet500/1000 mgIIIGeneric
FamciclovirFAMTAJAntiviralTablet250/500 mgIIIGeneric
GanciclovirGANCITAJAntiviralTablet/IV250/500 mgIIIGeneric
ValganciclovirVALGANCITAJAntiviralTablet450 mgIIIGeneric
OseltamivirOSELTTAJAntiviral (Influenza)Capsule30/45/75 mgIGeneric
ZanamivirZANATAJAntiviral (Influenza)Inhaler5 mgIGeneric
SofosbuvirHEPCITAJAntiviral (HCV)Tablet400 mgIIIGeneric in India (2018)
Sofosbuvir + VelpatasvirHEPCITAJ-VAntiviral (HCV)Tablet400/100 mgIIIGeneric in India (2019)
Ledipasvir + SofosbuvirHEPCITAJ-LAntiviral (HCV)Tablet90/400 mgIIIGeneric in India (2019)
DaclatasvirDACLITAJAntiviral (HCV)Tablet60 mgIIIGeneric in India (2018)
CidofovirCIDOTAJAntiviral (CMV)IV375 mg/5 mlIIIGeneric in India
FoscarnetFOSCTAJAntiviral (CMV)IV24 mg/mlIIIGeneric in India

Contract Manufacturing & Strategic Collaborations

At Taj Pharma, our advanced manufacturing and development division, we actively collaborate with global pharmaceutical companies, NGOs, and healthcare institutions through multiple partnership models.

CMO – Contract Manufacturing Organization

We provide end-to-end manufacturing services, including:

  • Technology transfer
  • Commercial-scale production
  • Packaging and serialization
  • Supply chain integration

Our CMO services are ideal for companies seeking a reliable ARV manufacturing base in India.


CDMO – Contract Development and Manufacturing Organization

We support:

  • New ARV formulation development
  • Process optimization
  • Scale-up and validation
  • Regulatory filing support

Our CDMO model ensures faster market entry with optimized cost structures.


Co-Development & In-Licensing

We actively explore:

  • Joint development of differentiated ARV products
  • In-licensing of niche or complex molecules
  • Long-term market expansion strategies

This collaborative approach allows partners to leverage our infrastructure while retaining strategic control.


Dedicated Research & Development Excellence

Our in-house R&D Centre, staffed with 25+ experienced scientists, is a cornerstone of our success in ARV manufacturing.

R&D Capabilities Include:

  • Formulation development
  • Analytical method validation
  • Stability studies (ICH zones)
  • Process optimization
  • Cost reduction strategies

We place strong emphasis on COGS optimization, ensuring our partners achieve maximum commercial competitiveness without compromising quality.


Global Regulatory & Compliance Strength

As a leading Anti-Retroviral Medicine Manufacturer in India, regulatory compliance is embedded in every stage of our operations.

We support:

  • CTD and eCTD dossier preparation
  • Country-specific regulatory submissions
  • WHO prequalification readiness
  • Pharmacovigilance and post-marketing surveillance

Our products are routinely supplied to Africa, Southeast Asia, CIS, Latin America, and regulated Western markets.


Quality Assurance & Patient Safety

Quality is not an obligation—it is our culture. Every ARV batch undergoes:

  • In-process quality controls
  • Finished product testing
  • Stability monitoring
  • Data integrity compliance

Our QA systems are aligned with global regulatory expectations, ensuring patient safety and consistent therapeutic outcomes.


Why Choose Taj Pharma as Your ARV Manufacturing Partner

  • 30+ years of pharmaceutical manufacturing expertise
  • Presence in 85+ countries
  • US-FDA, EU-GMP, UK-MHRA compliant facilities
  • High-volume, scalable ARV production
  • Proven cost optimization capabilities
  • Strong R&D and regulatory support
  • Flexible CMO, CDMO, and co-development models

Driving Global Access to Life-Saving Anti-Retroviral Therapies

We believe access to effective HIV treatment should never be limited by geography or affordability. Through innovation, scale, and uncompromising quality, Taj Pharma Limited continues to play a vital role in strengthening global HIV/AIDS treatment programs.

As a trusted Anti-Retroviral Medicine Manufacturer in India, we remain committed to supporting governments, healthcare providers, and global organizations in their mission to save lives and improve public health outcomes worldwide.